See also this year's filing and all EDGAR filings for this company.
PDF Report 0001100397_2016_Ayala_Pharmaceuticals_Inc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
Graph
Absolute values for 0001100397, Ayala Pharmaceuticals Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 115,014,573 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 3,355,033 |
| 2 | PropertyPlantAndEquipmentNet | 1,087,244 |
| 3 | remainder_Assets | 148,843 |
| 4 | LiabilitiesCurrent | 3,917,607 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 89,211 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 19,655,397 |
| 9 | ResearchAndDevelopmentExpense | 17,666,181 |
| 10 | remainder_Expenses | -1,761,307 |
| 11 | remainder_Revenues | 145,903 |
| 12 | remainder_NetIncome | 210,350 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 119,605,693 |
| 1 | Liabilities | 4,006,818 |
| 2 | Expenses | 35,560,271 |
| 3 | Revenues | 145,903 |
| 4 | StockholdersEquity | 115,598,875 |
| 5 | NetIncome | -35,204,018 |
| 6 | ComprehensiveNetIncome | -35,204,018 |
| 7 | BaseVar | 79,764,518 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 3.51 |
| 9 | EconomicCapitalRatio | 4.03 |
Edgar->Model Mapping
Feature Distribution
Change over Time
